| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00296-005-0031-1 |
| P698 | PubMed publication ID | 16189656 |
| P2093 | author name string | Takashi Yokoyama | |
| Wolfgang Ramlow | |||
| Nobuhito Kashiwagi | |||
| Doris Lange | |||
| Helmut Soerensen | |||
| Jana-Maria Schneidewind-Mueller | |||
| Marita Franz | |||
| P2860 | cites work | Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus | Q28269798 |
| Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
| Autoimmune diseases. | Q34325674 | ||
| Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis | Q34524019 | ||
| Abnormal B cell signal transduction in systemic lupus erythematosus | Q34984408 | ||
| Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes | Q35200770 | ||
| Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. | Q40415334 | ||
| Side-effects of intravenous cyclophosphamide pulse therapy | Q41432436 | ||
| Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA. | Q41924628 | ||
| Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study | Q43579980 | ||
| Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications | Q44130516 | ||
| Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
| Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis | Q44552976 | ||
| Endothelial cell destruction by polymorphonuclear leukocytes incubated with sera from patients with systemic lupus erythematosus (SLE) | Q67584752 | ||
| B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells | Q68100999 | ||
| A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group | Q68102206 | ||
| Defective regulation of B lymphocyte colony formation in patients with systemic lupus erythematosus | Q72100475 | ||
| A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis | Q73114791 | ||
| Novel roles of complement in systemic lupus erythematosus--hypothesis for a pathogenetic vicious circle | Q73613530 | ||
| Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes | Q74460375 | ||
| Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases | Q74477397 | ||
| Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum | Q74519125 | ||
| Anti-inflammatory effect of granulocyte and monocyte adsorption apheresis in a rabbit model of immune arthritis | Q74623215 | ||
| Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis | Q75287083 | ||
| A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis | Q77392678 | ||
| B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab | Q80502406 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 409-415 | |
| P577 | publication date | 2005-09-28 | |
| P1433 | published in | Rheumatology International | Q15763689 |
| P1476 | title | Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus. | |
| P478 | volume | 26 |
| Q90353156 | Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells |
| Q45114690 | First human application of a novel adsorptive-type cytapheresis module in patients with active ulcerative colitis: a pilot study |
| Q37345830 | Granulocytapheresis in the treatment of patients with active ulcerative colitis |
| Q30276550 | Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue |
| Q34122035 | Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis |
| Q91822155 | Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis |
| Q50940783 | Partial remission of refractory RA after Adacolumn cytapheresis: a case report. |
| Q53500011 | Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis. |
Search more.